# Efficacy and Safety of Implantable Cardioverter-Defibrillator (ICD) Implantation in the Elderly

Study · id `cardio:ct-nct02121158` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02121158](<https://clinicaltrials.gov/study/NCT02121158>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02121158

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease; Heart failure; Acute care and long-term living  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is terminated. It enrolled 167 participants.

## Technical summary

Registry record NCT02121158. Randomized; no masking; primary purpose treatment. Start 2015-08-07 (actual); primary completion 2020-11-06 (actual). Results posted on 2022-01-20.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 167 participants (enrolled count; ClinicalTrials.gov record NCT02121158, source copy `cardio:ctgov-nct02121158-2024-07-31`, retrieved 2026-10-26)
- Started: 2015-08-07 (actual) (ClinicalTrials.gov record NCT02121158, source copy `cardio:ctgov-nct02121158-2024-07-31`, retrieved 2026-10-26)
- Primary completion: 2020-11-06 (actual) (ClinicalTrials.gov record NCT02121158, source copy `cardio:ctgov-nct02121158-2024-07-31`, retrieved 2026-10-26)
- Completion: 2020-11-06 (actual) (ClinicalTrials.gov record NCT02121158, source copy `cardio:ctgov-nct02121158-2024-07-31`, retrieved 2026-10-26)
- Results first posted: 2022-01-20 (ClinicalTrials.gov record NCT02121158, source copy `cardio:ctgov-nct02121158-2024-07-31`, retrieved 2026-10-26)
- Countries: United States (ClinicalTrials.gov record NCT02121158, source copy `cardio:ctgov-nct02121158-2024-07-31`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "TERMINATED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02121158-2024-07-31`, retrieved 2026-10-26)

## The registry's words

- Brief title: Efficacy and Safety of Implantable Cardioverter-Defibrillator (ICD) Implantation in the Elderly
- Acronym: I-70
- Condition: Cardiomyopathy
- Condition: Coronary Artery Disease
- Condition: Congestive Heart Failure
- Condition: Myocardial Infarction
- Intervention (Device): Implantable Cardioverter Defibrillator
- Intervention (Other): Optimal Medical Therapy
- Lead sponsor: VA Office of Research and Development
- Lead sponsor class: FED

## Connected pages

- Registry condition terms include this condition: Cardiomyopathy (heart muscle disease) (`cardio:cardiomyopathy`)
- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)
- Registry condition terms include this condition: Heart failure (`cardio:heart-failure`)
- Registry condition terms include this condition: Heart attack (myocardial infarction) (`cardio:myocardial-infarction`)
- Registry lists this organization as the lead sponsor: VA Office of Research and Development (`cardio:org-va-office-of-research-and-development`)

## Provenance

Content hash: 686e24b420362fa58cc906bc091db7db19cfb50607a7b1291b6bf2bf442eb17d
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
